Astellas Pharma Inc Sustainability Reports

Astellas Pharma Inc. is a multinational pharmaceutical company that discovers, develops, manufactures, and commercializes innovative therapeutic products globally.

Sector: Manufacturing

Country: Japan

Exchange: Tokyo Stock Exchange

LEI: 529900IB708DY2HBBB35

FIGI: BBG001S6B9T0

45 reports from 2005 to 2026

• Astellas Pharma Inc 2026 Consolidated Financial Statements under IFRS with Independent Auditor's Report
• Astellas Pharma Inc 2025 Integrated Report
• Astellas Pharma Inc 2025 Consolidated Financial Statements under IFRS with Independent Auditor’s Report
• Astellas Pharma Inc 2025 Corporate Governance Report
• Astellas Pharma Inc 2025 Integrated Report